MHRA30 Mar 2026
Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18
The Medicines and Healthcare products Regulatory Agency published a recall notice for Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18 on 30 Mar 2026. It is one of 17 notices of this kind from MHRA since 26 Mar 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Medicines and Healthcare products Regulatory Agency
- Issued
- 10:16, 30 Mar 2026
- Alert class
- Class 2 Recall
- Official source
- Medicines and Healthcare products Regulatory Agency: the notice at its source
The latest from the MHRAEvery warning and recall in the United Kingdom
Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains public sector information licensed under the Open Government Licence v3.0.
The notice as issued
Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin following a stability failure for this batch. The batch has shown a reduction in potency of the Human Rabies immunoglobulin.
Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. The text is the agency's, unedited. Contains public sector information licensed under the Open Government Licence v3.0.